Yola Moride, PHD, FISPE, President & Founder

Professor Yola Moride is a globally recognized expert in pharmacoepidemiology, pharmacovigilance and therapeutic risk management. With over 25 years of experience in the conduct of observational drug utilization and risk evaluation studies, she is a Fellow, and former president, of the International Society for Pharmacoepidemiology (ISPE) as well as former Vice-President of the International Society of Pharmacovigilance (ISoP). She has conducted many studies using administrative claims, electronic medical records, and primary data collection in the US, Europe, Canada. She is also an expert in the methods of signal detection and assessment, methods of evaluation of effectiveness of risk minimization and mitigation strategies.

She holds academic, regulatory, and hospital appointments. Prof. Moride is a Full Professor, Faculty of Pharmacy, at the Université de Montréal; and a Visiting Professor at the Université Victor Segalen Bordeaux 2. She is a researcher at the Pharmacoepidemiology Unit of the University of Montréal Hospital Research Center (CRCHUM).

She is currently developing a micro-programme in Pharmacovigilance & Therapeutic Risk Management at the Université de Montréal. She has organized several knowledge transfer and communication activities, such as the Canadian Symposia in Therapeutic Risk Management (2006, 2009, 2012). She was co-chair and member of the local host committee of the 33^rd International Conference on Pharmacoepidemiology (ICPE) (Montreal, August 2017) and has also chaired the 29^th International Conference on Pharmacoepidemiology (Montreal, August 2013), and served on the scientific committee of the Annual ISoP conference (Prague, October 2015).

Prof. Moride is an appointed member of the CIOMS Working Group IX, the European Medicines Agency’s Steering Group of the ENCePP, and a member of Health Canada’s Science Advisory Board. She has currently over 90 articles published in peer-reviewed journals including the NEJM and BMJ. She has made over 85 presentations at scientific conferences, authored 11 book chapters, and delivered over 70 invited speaking engagements. She holds degrees in Genetics (MSc) and Pharmacoepidemiology (PhD) from McGill University and has trained as a Post-doctoral Fellow at the Pharmacovigilance Centre at the University of Bordeaux (France).